Free

Preparing for the Future of Fentanyl

Event Information

Share this event

Date and Time

Location

Location

Drug Policy Alliance

131 West 33rd Street

15th Floor

New York, NY 10001

View Map

Event description
Dr. Bryce Pardo will discuss past and current trends in fentanyl overdoses and offer innovative policy solutions for the future.

About this Event

Drug Policy Alliance's Office of Academic Engagement and SUNY-Stonybrook present the Drug Researchers’ Roundtable (#DrugResearchersRT), a monthly meeting for academics and researchers in the field of drug policy, criminology, and addiction and related fields to present their work to fellow New York based scholars, academics, researchers, and drug policy advocates.

For our December Drug Researchers' Roundtable, we are excited to host Dr. Bryce Pardo!

Talk description

The rates of overdose fatalities involving heroin or prescription opioids have slowed in recent years but are now outnumbered by overdoses involving synthetic opioids. The introduction of illicitly manufactured synthetic opioids like fentanyl to U.S. drug markets has presented new challenges for policymakers working to reverse this public health crisis. What do policymakers need to consider in their efforts to address this threat in the United States? RAND researchers recently analyzed the past, present, and possible futures of fentanyl in the United States. In this briefing, Dr. Bryce Pardo, associate policy researcher discuss:

• Recent trends in U.S. fatal overdoses and drug seizures

• Factors that have contributed to the rise of synthetic opioids in the U.S.

• What the future of fentanyl and other synthetic opioids looks like

• Traditional and non-traditional policy options for addressing fentanyl problems

About the speaker

Bryce Pardo is an associate policy researcher at the RAND Corporation. His work focuses on drug policy with a particular interest in the areas of cannabis regulation, opioid control, and new psychoactive substance markets. He has over ten years of experience working with national, state, and local governments in crime and drug policy. Recently, he has provided Congressional testimony about his research on illicit supply of fentanyl to several subcommittees within the U.S. House of Representatives. Prior to joining RAND, he served five years as a legislative and policy analyst at the Inter-American Drug Abuse Control Commission (CICAD) within the Organization of American States (OAS) where he worked directly with policymakers and practitioners. He has independently consulted with multi-lateral institutions, including the Pan-American Health Organization (PAHO) and the United Nations Office on Drugs and Crime (UNODC). Pardo also served as lead analyst with BOTEC Analysis Corporation to support the Government of Jamaica in drafting medical cannabis regulations. His research and academic works have been published in the International Journal of Drug Policy, Addiction, Lancet Psychology, Criminology and Public Policy, and reports for the London School of Economics, UNODC, PAHO, and the National Academy of Sciences. Pardo holds a Ph.D. in public policy from the University of Maryland, College Park and an M.A. in Latin American studies and a B.A. in political science from the George Washington University.

Event accessibility

The event is wheelchair accessible and will take place on 131 W 33rd Street, 15th floor. There is a gender-neutral restroom. To respect people with allergies or environmental sensitivities, please refrain from wearing strong fragrances. If taking public transportation, the nearest wheelchair accessible subway stations are 34th Street - Penn Station and 34th Street - Herald Square. If you have questions or need accommodations, please email acohen@drugpolicy.org or call Aliza Cohen at 212.613.8055.

Share with friends

Date and Time

Location

Drug Policy Alliance

131 West 33rd Street

15th Floor

New York, NY 10001

View Map

Save This Event

Event Saved